Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00031915

Locations


United States, California
	Jonsson Comprehensive Cancer Center, UCLA
	Los Angeles, California, United States, 90095-1781

United States, District of Columbia
	Washington Hospital Center
	Washington, District of Columbia, United States, 20010

United States, Illinois
	Lutheran General Cancer Care Center
	Park Ridge, Illinois, United States, 60068

United States, Maryland
	Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
	Bethesda, Maryland, United States, 20892-1182

United States, Massachusetts
	Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
	Boston, Massachusetts, United States, 02115

United States, Michigan
	University of Michigan Comprehensive Cancer Center
	Ann Arbor, Michigan, United States, 48109-0912

United States, Minnesota
	Mayo Clinic Cancer Center
	Rochester, Minnesota, United States, 55905

United States, New York
	Herbert Irving Comprehensive Cancer Center at Columbia University
	New York, New York, United States, 10032
	Memorial Sloan-Kettering Cancer Center
	New York, New York, United States, 10021-6007

United States, Texas
	University of Texas - MD Anderson Cancer Center
	Houston, Texas, United States, 77030-4009

Sponsors and Collaborators

National Cancer Institute (NCI)

Investigators


Study Chair:	Lee J. Helman, MD	NCI - Pediatric Oncology Branch